Juvenile Idiopathic Arthritis
Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.
Teenagers with juvenile idiopathic arthritis and their parents enjoyed participating in an internet-based intervention designed to improve accessibility and disease self-management.
Patients with juvenile idiopathic arthritis receiving biologic therapy have high rates of serious infections.
Technological advances can be helpful in juvenile idiopathic arthritis and are particularly well suited to younger people in general, who are more comfortable with device technologies and more likely to adopt them.
In patients with juvenile idiopathic arthritis, levels of serum vitamin D are closely related to cholesterol levels and other risk factors for cardiovascular disease.
Children with juvenile idiopathic arthritis using anti-TNFIs have a significantly higher risk for infection compared with children using DMARDs.
Clinical Pain Advisor Articles
- Opioid Use in Chronic Low Back Pain: A Population Study
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes
- Education Plus Exercise, Single Corticosteroid Injection Effective in Long Term for Gluteal Tendinopathy
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Naloxone Training Beneficial for PA Students
- Supervised Injection Sites Hailed as the Latest Strategy to Fight the Opioid Crisis